Photocatalytic activity of CuO/Cu(OH)2 nanostructures in the degradation of Reactive Green 19A and textile effluent, phytotoxicity studies and their biogenic properties (antibacterial and anticancer).

In this study, CuO/Cu(OH)2 (denoted as CuONs) nanostructures were synthesized relying to a cheap and rapid chemical co-precipitation method using copper sulfate and liquid ammonia as precursors. Results obtained from X-ray diffraction, and field emission scanning electron microscopy analysis revealed the crystalline nature of synthesized CuONs. Fourier transform infrared spectroscopy and energy dispersive spectroscopy studies showed interactions between copper and oxygen atoms. Synthesized CuONs showed the size in the range of 20-30 nm using high resolution transmission electron microscopy analysis. The photocatalytic degradation performance of Reactive Green 19A (RG19A) dye using CuONs was evaluated. The results showed that CuONs exhibited 98% degradation efficiency after 12 h and also complete mineralization in form of reducing chemical oxygen demand (COD) (84%) and total organic carbon (TOC) (80%). The nanocatalyst was recovered from the dye containing solution and its catalytic activity can be reused up to four times efficiently. CuONs was also able to decolorize actual textile effluent (80% in terms of the American Dye Manufacturers' Institute (ADMI) value) with significant reductions in COD (72%) and TOC (69%). Phytotoxicity studies revealed that the degradation products of RG19A and textile effluent were scarcely toxic in nature, thereby increasing the applicability of CuONs for the treatment of textile wastewater. Additionally, the CuONs showed a maximum antibacterial effect against human pathogens which also displayed synergistic antibacterial potential related to commercial antibiotics. Moreover, CuONs displayed strong antioxidant activity in terms of ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (IC50: 51 μg/mL) and DPPH (1,1-diphenyl-2-picrylhydrazyl) (IC50: 60 μg/mL) radical scavenging. The CuONs exhibited dose dependent response against tumor rat C6 cell line (IC50: 60 μg/mL) and may serve as anticancer agents.